Seeking Alpha

Penn Bioinvestor » Articles |

Sort by:
Latest | Editors' Picks | Most Commented | Most Popular
Articles by Ticker

Latest Comments on Penn Bioinvestor's Articles

  1. Penn Bioinvestor on Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor: I am proud to say so far I have the best prediction record.(My... more »
  2. jsc on Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor: What is the hold up on the FDA results. It was my understanging... more »
  3. FDAwatch on Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor: "The FDA decision date coming close makes it a very high risk... more »
  4. TMC on Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor: MAYBE THE FDA DIDN"T APPROVE TSPT, BECAUSE IT IS GOING TO APPROVE... more »
  5. Robert0713 on Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor: >> Histamine is an important waking neurotransmitter, and the... more »
  6. Penn Bioinvestor on Theravance, Inc.: Wait to Buy on Dip: No surprise, Theravance says FDA delays new Vitabiv... more »
  7. Penn Bioinvestor on Theravance, Inc.: Wait to Buy on Dip: Theravance's Horizon program is a long-acting beta2 agonist that... more »
  8. Penn Bioinvestor on Theravance, Inc.: Wait to Buy on Dip: On September 11, 2009, the U.S. Food and Drug Administration (FDA)... more »
  9. dharma_bear on Theravance, Inc.: Wait to Buy on Dip: ''The FDA is anticipated to decide on 11/26/09 for Vibativ... more »
  10. Penn Bioinvestor on Vivus: Obesity Experimental Drug Has Promising Outlook: Where are all those bashers? Come out and check the big day for VVUS. more »
  11. Penn Bioinvestor on Vivus: Obesity Experimental Drug Has Promising Outlook: Where are all those bashers??? more »
  12. bestinclass on Vanda Pharmaceuticals: Heavily Undervalued: The CEO of VNDA is overly optimistic because he wants to inflate... more »
  13. Penn Bioinvestor on Vivus: Obesity Experimental Drug Has Promising Outlook: Looked a bunch of ARNA fans posted comments here. Thanks for... more »
  14. dakyne on Vivus: Obesity Experimental Drug Has Promising Outlook: Nice post Philly Dan. I'm astounded at what passes as... more »
  15. pharmaman on Vivus: Obesity Experimental Drug Has Promising Outlook: Hey PhillyDan, What do you think are the shortcomings of... more »